CRGX Utang jangka cendhak perusahaan CARGO Therapeutics, Inc

CARGO Therapeutics (CRGX) utilizes US CDMO capacities for the flexible production of drugs according to cGMP standards. The success of new blood treatment methods could grant the firm pricing power within its niches. This daily price chart reflects the asset's dynamics, where the metric stands at 0.00. The future implementation of automated bioreactors will eliminate human error during cell cultivation.

CRGX Utang jangka cendhak cargo-tx.com (21.02.2024 - 30.08.2025)

Rincian analitis lan laporan data perusahaan CARGO Therapeutics, Inc (CRGX)

- kuotasi saiki lan rata-rata prakiraan nilai:

Bagan rega CARGO Therapeutics, Inc.|CRGX - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Nilai pasar CARGO Therapeutics, Inc.|CRGX - Nilai Total Perusahaan

- data nilai buku modal saham:

Aset Bersih saben Siji Saham CARGO Therapeutics|CRGX - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku cargo-tx.com|CRGX - Aset Neraca Perusahaan

- indikator total utang lan likuiditas perusahaan:

Rasio Total Utang marang Ekuitas CARGO Therapeutics|CRGX - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas CARGO Therapeutics|CRGX - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku CARGO Therapeutics, Inc.|CRGX - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan CARGO Therapeutics|Likuiditas cepet cargo-tx.com

- data bathi lan kelipatan valuasi:

CRGX - Bathi resik perusahaan

Analisis umum perusahaan:CARGO Therapeutics, Inc. (CRGX)

To protect capital amid market volatility, it is critical for investors to assess the liquidity of liabilities with maturities of up to one year. By analyzing the short-term debt trend, one can determine the extent to which the high burn rate for CAR-T therapy biomanufacturing and clinical risks exert pressure on the CARGO Therapeutics (CRGX) balance sheet, defining the asset's overall resilience to credit stress.

Analisis pesaing